Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates

scientific article

Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2011PLoSO...616622A
P356DOI10.1371/JOURNAL.PONE.0016622
P932PMC publication ID3034725
P698PubMed publication ID21326877
P5875ResearchGate publication ID49841501

P50authorAnand SrivastavaQ55175663
Benoit GamainQ55175836
Sebastien DechavanneQ61099536
Mirja HommelQ61820707
P2093author name stringJoseph D Smith
James G Beeson
Marion Avril
Marianne J Hathaway
P2860cites workAntigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparumQ24533320
Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSAQ24620671
The Structure of a Chondroitin Sulfate-binding Domain Important in Placental MalariaQ27650818
Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate AQ27653526
Structural Comparison of Two CSPG-Binding DBL Domains from the VAR2CSA Protein Important in Malaria during PregnancyQ27657099
Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malariaQ27976511
The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of plasmodium falciparum-infected erythrocytesQ29393314
Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytesQ29618254
Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytesQ29618991
IgM, Fc mu Rs, and malarial immune evasionQ30432532
Epitope mapping and topographic analysis of VAR2CSA DBL3X involved in P. falciparum placental sequestrationQ33263953
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasitesQ33286064
Disruption of var2csa gene impairs placental malaria associated adhesion phenotypeQ33299476
Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSAQ33320197
Several domains from VAR2CSA can induce Plasmodium falciparum adhesion-blocking antibodiesQ33634689
Cross-reactive surface epitopes on chondroitin sulfate A-adherent Plasmodium falciparum-infected erythrocytes are associated with transcription of var2csaQ33769127
Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant womenQ33826049
Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytesQ33826076
Subtelomeric chromosome deletions in field isolates of Plasmodium falciparum and their relationship to loss of cytoadherence in vitroQ33848276
Identification of Plasmodium falciparum var1CSA and var2CSA domains that bind IgM natural antibodiesQ33849078
Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodiesQ34095324
A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A.Q34360455
Evidence for the involvement of VAR2CSA in pregnancy-associated malariaQ34364093
A family affair: var genes, PfEMP1 binding, and malaria diseaseQ34543611
Baculovirus-expressed constructs induce immunoglobulin G that recognizes VAR2CSA on Plasmodium falciparum-infected erythrocytesQ34721210
Transcribed var genes associated with placental malaria in Malawian women.Q34975870
The sick placenta-the role of malaria.Q35744707
Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newbornsQ36374795
Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA.Q36539548
Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodiesQ36789977
Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites.Q36891434
An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotypeQ36974515
Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic propertiesQ37036123
Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targetsQ37036128
Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA.Q37204480
Optimizing expression of the pregnancy malaria vaccine candidate, VAR2CSA in Pichia pastorisQ37271796
Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSAQ37426131
Structural basis for binding of Plasmodium falciparum erythrocyte membrane protein 1 to chondroitin sulfate and placental tissue and the influence of protein polymorphisms on binding specificityQ38300914
High level of var2csa transcription by Plasmodium falciparum isolated from the placentaQ38324821
Variable adhesion abilities and overlapping antigenic properties in placental Plasmodium falciparum isolatesQ39537054
Plasmodium falciparum: VAR2CSA expressed during pregnancy-associated malaria is partially resistant to proteolytic cleavage by trypsinQ40144118
Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasitesQ41459429
Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasitesQ43415044
High efficacy of anti DBL4ɛ-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant womenQ43941189
VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytesQ44956636
Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placentaQ45249046
VAR2CSA domains expressed in Escherichia coli induce cross-reactive antibodies to native proteinQ46608178
Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malariaQ47232540
Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA.Q47765536
Maternal antibodies block malariaQ47838841
Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in ThailandQ47858805
Plasmodium falciparum-infected erythrocytes demonstrate dual specificity for adhesion to hyaluronic acid and chondroitin sulfate A and have distinct adhesive propertiesQ47973172
VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparumQ48028019
Plasmodium falciparum: Effect of time in continuous culture on binding to human endothelial cells and amelanotic melanoma cellsQ57044377
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)e16622
P577publication date2011-02-07
P1433published inPLOS OneQ564954
P1476titleAntibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates
P478volume6

Reverse relations

cites work (P2860)
Q51417360A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection.
Q36804761Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue
Q36354336Beninese children with cerebral malaria do not develop humoral immunity against the IT4-VAR19-DC8 PfEMP1 variant linked to EPCR and brain endothelial binding
Q33911270CRISPR/Cas9 Genome Editing Reveals That the Intron Is Not Essential for var2csa Gene Activation or Silencing in Plasmodium falciparum
Q39066692Comparison of functional assays used in the clinical development of a placental malaria vaccine
Q34498103Designing a VAR2CSA-based vaccine to prevent placental malaria
Q38519513Developing vaccines to prevent malaria in pregnant women
Q43171908Expanding the toolbox in pursuit of a strain transcendent malaria vaccine
Q93109754Functional Antibodies against Placental Malaria Parasites Are Variant Dependent and Differ by Geographic Region
Q47999224Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies
Q36668512Identification of VAR2CSA domain-specific inhibitory antibodies of the Plasmodium falciparum erythrocyte membrane protein 1 using a novel flow cytometry assay
Q35783076Identification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA.
Q27301377Immunogenicity of the Plasmodium falciparum PfEMP1-VarO Adhesin: Induction of Surface-Reactive and Rosette-Disrupting Antibodies to VarO Infected Erythrocytes
Q36558721Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria
Q37002285Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy
Q89595553PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study
Q92632114Phosphorylation of the VAR2CSA extracellular region is associated with enhanced adhesive properties to the placental receptor CSA
Q38691920Pre-clinical and clinical development of the first placental malaria vaccine
Q64086386Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC
Q35738477Prospects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites
Q36078717Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria.
Q34161839Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates
Q39698908The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria
Q34921119VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta
Q30401849Vaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A Virus
Q28744428Var2CSA minimal CSA binding region is located within the N-terminal region

Search more.